AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Background The role of catheter ablation in patients with symptomatic atrial fibrillation and
end-stage heart failure is unknown. Methods We conducted a single-center, open-label trial …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Sudden cardiac death, arising from abnormal electrical conduction, occurs frequently in
patients with coronary heart disease. Myocardial ischemia simultaneously induces …

Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Background: Various noninvasive intermittent rhythm monitoring strategies have been used
to assess arrhythmia recurrences in trials evaluating pharmacological and invasive …

Aims Atrial tachyarrhythmia recurrence≥ 30 s remains the primary endpoint of clinical trials;
however, this definition has not been correlated with clinical outcomes or pathophysiological …

Background Catheter ablation is an effective strategy in atrial fibrillation (AF). However, its
timing in the course of management remains unclear. The aim of this study was to determine …

Importance Patients with atrial fibrillation (AF) have impaired health-related quality of life
primarily owing to symptoms related to AF episodes; however, quality of life can be …

Atrial fibrillation is increasingly encountered in patients with heart failure. Both diseases
have seen tremendous rises in incidence in recent years. In general, the treatment of atrial …